Barr Labs erythromycin recall

Generic drug firm initiating Class I recall of approximately 335 bottles of liquid erythromycin ethylsuccinate due to a labeling mix-up that "could have serious health consequences for individuals who are allergic to 'sulfa drugs,'" Pomona, N.Y.-based Barr announced Nov. 26. In addition to erythromycin ethylsuccinate, the bottles being recalled contain sulfisoxazole acetyl, which can cause allergic reactions ranging from "mild discomfort to, in rare cases, life-threatening respiratory distress," Barr said. The nationwide recall to the consumer level involves the stock of the antibiotic received during the previous 30 days with the lot number 1l445AW. . . .